DANA-FARBER CANCER INSTITUTE, INC. Patent Application Trends in 2025
DANA-FARBER CANCER INSTITUTE, INC. Patent Filing Activity
DANA-FARBER CANCER INSTITUTE, INC. patent applications in 2025
Top 10 Technology Areas
- A61P35/00 (Antineoplastic agents)
- Count: 5 patents
- Example: 20250034126. CHROMOBOX PROTEIN INHIBITORS AND USES THEREOF (Dana-Farber Cancer Institute, Inc.)
- A61K31/506 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
- Count: 4 patents
- Example: 20250066326. BCL6 DEGRADERS AND USES THEREOF (Dana-Farber Cancer Institute, Inc.)
- A61K45/06 (Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca)
- Count: 4 patents
- Example: 20250092114. NKG2D-FC FOR IMMUNOTHERAPY (Dana-Farber Cancer Institute, Inc.)
- C12Q1/6886 (for cancer (immunoassay for cancer)
- Count: 2 patents
- Example: 20250034652. C-RAF Mutants that Confer Resistance to RAF Inhibitors (DANA-FARBER CANCER INSTITUTE, INC.)
- C07D401/14 (HETEROCYCLIC COMPOUNDS (macromolecular compounds)
- Count: 2 patents
- Example: 20250066326. BCL6 DEGRADERS AND USES THEREOF (Dana-Farber Cancer Institute, Inc.)
- C07K16/2827 (PEPTIDES (peptides in foodstuffs)
- Count: 2 patents
- Example: 20250066481. FC VARIANT COMPOSITIONS AND METHODS OF USE THEREOF (Dana-Farber Cancer Institute, Inc.)
- C07K2317/52 (PEPTIDES (peptides in foodstuffs)
- Count: 2 patents
- Example: 20250066481. FC VARIANT COMPOSITIONS AND METHODS OF USE THEREOF (Dana-Farber Cancer Institute, Inc.)
- C12N2510/00 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media)
- A61K31/4545 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms)
- A61K47/6803 ({Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates})
Emerging Technology Areas
- C07K2319/74 (PEPTIDES (peptides in foodstuffs)
- C07K2319/33 (PEPTIDES (peptides in foodstuffs)
- C07K2319/03 (PEPTIDES (peptides in foodstuffs)
- C07K2317/622 (PEPTIDES (peptides in foodstuffs)
- C07K2317/60 (PEPTIDES (peptides in foodstuffs)
- C07K2317/515 (PEPTIDES (peptides in foodstuffs)
- C07K2317/51 (PEPTIDES (peptides in foodstuffs)
- C12Y402/01001 (ENZYMES)
- C12N9/88 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media)
- C12N5/0638 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media)
Top Inventors
- Loren D. Walensky of Newton MA (US) (2 patents)
- Barbel Schrofelbauer of Somerville MA (US) (2 patents)
- Patrick Kimes of San Francisco CA (US) (2 patents)
- William Hahn of Newton MA (US) (2 patents)
- James E. Bradner of Weston MA (US) (1 patent)
- Jun Qi of Sharon MA (US) (1 patent)
- Alexander Federation of Seatte WA (US) (1 patent)
- Zoe Jacobson of San Francisco CA (US) (1 patent)
- Anthony Varca of Boston MA (US) (1 patent)
- Caroline Emery of Kansas City MO (US) (1 patent)
Patent Categories
Geographical Distribution of Inventors
Geographical Distribution of US Inventors
Categories:
- DANA-FARBER CANCER INSTITUTE, INC.
- Companies
- CPC C07D417/12
- CPC A61P35/00
- CPC C07D277/54
- CPC C07D405/04
- CPC C07D417/14
- CPC C07D471/04
- CPC C12Q1/6886
- CPC C12N9/12
- CPC C12Q2600/106
- CPC C12Q2600/156
- CPC C12Y207/11001
- CPC A61K35/74
- CPC A61K39/0011
- CPC A61K39/001139
- CPC A61K39/105
- CPC C07K14/205
- CPC A61K2039/55522
- CPC A61K2039/55555
- CPC A61K2039/55561
- CPC A61K2039/6068
- CPC A61K2039/645
- CPC C07D401/14
- CPC A61K31/506
- CPC C07K16/2827
- CPC C07K16/2866
- CPC C07K16/2878
- CPC C07K2317/31
- CPC C07K2317/52
- CPC C07K2317/732
- CPC C12N5/0696
- CPC A61K35/12
- CPC C12N2506/115
- CPC C12N2510/00
- CPC A61K31/4402
- CPC A61K31/4545
- CPC A61K31/713
- CPC A61K31/4709
- CPC A61K31/5377
- CPC A61K31/553
- CPC C07D405/14
- CPC C07D413/14
- CPC C07D498/04
- CPC G01N33/5306
- CPC C07K14/395
- CPC G01N33/57488
- CPC G01N2333/4703
- CPC C07K14/70596
- CPC A61K38/177
- CPC A61K45/06
- CPC C07K14/7056
- CPC C07K2319/30
- CPC C12Q1/6851
- CPC C12Q2600/166
- CPC C12Q2600/178
- CPC C07K14/005
- CPC A61K47/554
- CPC A61K47/60
- CPC A61P31/14
- CPC C12N2770/20022
- CPC C12N2770/20033
- CPC A61K47/6803
- CPC A61K47/6849
- CPC G01N33/5011
- CPC G01N33/6854
- CPC A61K2039/505
- CPC C07K16/2896
- CPC G01N33/57492
- CPC C07K2317/24
- CPC C07K2317/565
- CPC C07K2317/569
- CPC C07K2317/76
- CPC G01N2333/70596
- CPC G01N2474/20
- CPC C12N15/1037
- CPC G01N33/6848
- CPC G01N2333/70578
- CPC A61K31/502
- CPC A61K31/352
- CPC A61K31/381
- CPC A61K31/5025
- CPC A61K31/517
- CPC A61K31/7068
- CPC C07K16/30
- CPC A61K38/2013
- CPC A61K39/4611
- CPC A61K39/4631
- CPC A61K39/464454
- CPC A61K2239/31
- CPC A61K2239/38
- CPC A61K2239/56
- CPC C07K14/7051
- CPC C07K14/70521
- CPC C07K16/40
- CPC C12N5/0636
- CPC C12N5/0637
- CPC C12N5/0638
- CPC C12N9/88
- CPC C12Y402/01001
- CPC C07K2317/51
- CPC C07K2317/515
- CPC C07K2317/60
- CPC C07K2317/622
- CPC C07K2319/03
- CPC C07K2319/33
- CPC C07K2319/74
- Patent Trends by Company in 2025